MDXHMDxHealth SA American Depositary Shares

NAS · US · Healthcare · Diagnostics & Research · mdxhealth.com

0.7431USDMkt Cap: 70.90M $P/E: —3d ago

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Confirm mdx for prostate cancer tissu…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

$44.91BUSDP/E 31.9

IDXX

IDEXX Laboratories, Inc.

Mettler-Toledo International, Inc.

$27.96BUSDP/E 31.5

Labcorp Holdings Inc.

$27.28BUSDP/E 27.8

DGX

Quest Diagnostics Incorporated

$26.97BUSDP/E 26.0

Guardant Health, Inc.

$22.91BUSD

MEDP

Medpace Holdings, Inc.

$17.33BUSDP/E 36.4

ERF

Eurofins Scientific SE

$13.65BUSDP/E 25.3

CRL

Charles River Laboratories International, Inc.

$14.09BUSD

RVTY

Revvity Inc. Common Stock

$13.92BUSDP/E 59.7

ICLR

ICON Public Limited Company

Twist Bioscience Corp.

$9.13BUSD

Key Statistics

Company

Market Cap70.90M $

Enterprise Value124.90M $

Revenue (TTM)114.02M $

Gross Profit69.63M $

Net Income (TTM)-33.52M $

Revenue/Share2.265 USD

Last Price0.7431 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees364

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-1.89

PEG—

EV/EBITDA-8.37

EV/Revenue1.10

P/S0.60

P/B-1.24

EPS (TTM)-0.71

EPS (Forward)-0.38

52W Range

0.712782% of range0.7500

52W High0.7500 USD

52W Low0.7127 USD

Profitability

Gross Margin64.55%

Oper. Margin-18.74%

EBITDA Margin-13.09%

Profit Margin-31.07%

ROE277.15%

ROA-22.66%

Growth

Revenue Growth2.30%

Earnings Growth—

Cash Flow & Leverage

Operating CF-2.19M $

CapEx (TTM)1.16M $

FCF Margin-13.09%

FCF Yield-21.05%

Net Debt86.64M $

Net Debt/EBITDA-5.80

Balance Sheet

Debt/Equity-7.16

Current Ratio1.15

Quick Ratio0.91

Book Value/Sh-0.5800 USD

Cash/Share0.3660 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.7 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)2.200 USD

Upside (mean)+196.1%

Target Range1.000 USD – 4.000 USD

$1.000+196.1% to mean$4.000

# Analysts5

Ownership

Shares Out.95.42M

Float39.96M

Insiders22.14%

Institutions45.19%

Short Interest

Short Ratio2.4d

Short % Float2.74%

Short % Out.2.07%

Shares Short1.06M

Short (prev mo.)33.04K

Technical

SMA 500.4909 (+51.4%)

SMA 2002.311 (-67.8%)

Beta-501440.84

S&P 52W Chg21.00%

Avg Vol (30d)391.42K

Avg Vol (10d)35.05M

Technical Indicators

RSI (14)65.7

MACD0.0708

MACD Signal0.0341

MACD Hist.+0.0367

BB Upper0.8599 USD

BB Middle0.5375 USD

BB Lower0.2150 USD

BB Width120.01%

ATR (14)0.0897 USD

Vol Ratio (20d)0.02x